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ABSTRACT
Introduction: The opioid epidemic as a social problem has increasingly received more attention from the mass 
media as well as the scientific community. Despite all this attention substance use disorders involving 
prescription pain relievers affect roughly 1.9 million Americans annually. Aims: The purpose of this study was to 
understand the impact of mental health and risky behaviors such as alcohol use on propensity for non-medical 
prescription pain reliever use. Design & Methods: The data for this study came from the 2014 National Survey 
on Drug Use and Health A multivariate logistic regression analysis was run on a number of variables pulled 
from the survey. Results: The study showed that certain mental conditions and risky behaviors increase one’s 
propensity for non-medical prescription pain reliever use. Discussion: The findings of the study suggest (1) 
future research is necessary to understand further the correlations among mental health, risky behavior, and 
non-medical prescription pain reliever use; (2) that greater attention by all stakeholders to one’s mental health 
history is a significant factor in affecting the aforementioned epidemic; and (3) that greater attention to individual 
willingness to participate risky behavior (e.g., frequent alcohol consumption) could significantly impact the 
epidemic. Conclusion: The findings in this study can potentially assist healthcare providers in safer prescribing 
practices as well as other practical applications. With a broader knowledge of conditions correlated to the use of 
prescription pain relievers for non-medical reasons, the medical community could engage in safer prescribing of 
this potent medication. 
Introduction 
The U.S. has seen a steady increase in prescription drug abuse since 
the mid-1990’s [1]. The aggressive treatment of pain as a chronic 
incurable condition has led to a large influx in availability of pre-
scription drugs [2]. The U.S. alone accounts for 80% of the world’s 
opioid supply and 99% of the world’s hydrocodone supply [3]. This 
epidemic cost insurers 72.5 billion dollars in 2007 [4]. Though the 
problem of prescription drug abuse is not new to this country, the 
severity of the problem has reached new proportions [5]. 
Along with this influx, a gap has developed in understanding what 
conditions correlate with the use of prescription pain relievers for 
the purpose of getting high. The abuse of this supply of pain re-
liever medication demands the attention of the scientific commu-
nity; a need exists to further understand some of the behaviors and 
mental conditions that contribute to prescription pain reliever mis-
use. The purpose of this study is to examine the impact of depres-
sion, mental distress, and social anxiety as well as alcohol consump-
tion on the likelihood of using opioids non-medically in hopes of 
providing a greater understanding of this epidemic. 
Literature Review
Periods of Depression & Opioid Use
With substance use disorder being at the heart of the opioid epi-
demic [4] it is important to understand certain traits an individual 
may possess that make him or her more susceptible to non-medical 
prescription pain reliever use. Mood disorders such as depression 
often go hand in hand with non-medical prescription opioid use [6]. 
Studies have shown that individuals who take higher dosages of 
pain medication also report periods of depression more frequently 
than those who are taking a lower dose [7,8]. 
Those who report depression are at a much higher risk of long term 
pain reliever misuse [7,9]. In many cases individuals that have 
never experienced any form of substance use in the past report pain 
reliever abuse to alleviate depressive symptoms [10].  Those that 
may have initially received their prescription for the purpose of 
treating acute pain are in turn far more inclined to take these 
opioids to treat the mental pain of their depressive symptoms [10]. 
 The consumption of these opioids in order to relieve mental pain 
provides a paradox of sorts for the user, being that the depressive 
symptoms often worsen as the frequency of self-medication in-
creases [8,9]. The user becomes dependent upon the opioids physi-
cally as well as mentally, which in turn can intensify the initial de-
pressives symptoms [11]. Being that drug misuse is already signifi-
cantly higher in individuals who report depression [12], I propose 
the following hypothesis: 
H1: Individuals who experience periods of depression are more 
likely to use prescription pain relievers non-medically than those 
who do not experience periods of depression.
Mental Distress & Opioid Use
 Mental distress can manifest itself through a variety of psychiatric 
conditions such as suicidal ideations and manic depressive episodes 
[13]. These conditions in turn can also be linked to a highly-
elevated risk of drug misuse [6,7,10,12,14]. Those who report a 
high level of mental distress in their life often characterized by feel-
ings of hopelessness, restless nights and low self-worth, are much 
more susceptible to develop substance use disorders [15]. 
 A recent study on suicidality and non–medical prescription drug 
misuse found that those who displayed symptoms such as feelings 
of hopelessness and low self-worth showed some of the strongest 
correlations in non-medical prescription drug misuse [16]. The in-
creased level of dopamine this opioid medication provides and the 
subsequent euphoric experience serves to kill some of the mental 
pain which accompanies this level of distress [17]. The medication 
can provide relief from intense feelings of hopelessness and provide 
one with an acceptance of their environment that was not previ-
ously attainable in their mental state [17]. Accordingly, I hypothe-
size the following: 
H2: Those who experience frequent mental distress in their lives 
are more likely to use prescription pain relievers non-medically 
than those who do not experience frequent mental distress in their 
lives. 
Social Anxiety and Prescription Pain Reliever Misuse: 
Social anxiety disorder, i.e., an inability to perform daily tasks 
within one’s social setting such as small talk with strangers, com-
monly correlates with substance use [18-20]. It often goes hand in 
hand with depressive episodes and can be linked to a variety of 
other forms of mental illness [21]. Pharmacotherapy is often util-
ized in the medical community as a treatment for social anxiety dis-
order, so it is easy to understand how an individual may experience 
relief via self-administered opioid medication [21]. Though the 
medications administered for this condition are not entirely similar 
in their effects they are each associated with higher concentrations 
of dopamine in the brain and are similar in this regard [21-23]. 
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 Prescription drug abuse being somewhat easy to conceal as op-
posed to other substances becomes a prime method of escape for 
individuals who experience emotional unrest in social settings [24]. 
These effects allow one’s social environment to become much more 
acceptable and tolerable whereas prior to the pain reliever use the 
individual found their social duties almost impossible to carry out. 
Falling in line with what is stated above an inability to connect with 
one’s social environment can lead to feelings of low self-worth and 
other forms of more serious mental distress which in turn makes 
one more susceptible to prescription pain reliever misuse [6,15]. It 
was based upon this research that I  proposed the following hypothe-
sis:
H3:  Those who experience social anxiety are more likely to use 
prescription pain relievers non-medically than those who do not 
experience social anxiety. 
Alcohol Use & Prescription Opioids
Periods of depression and other mental health conditions have dem-
onstrated a positive correlation with a propensity for alcohol use 
[25]. Research also shows that individuals who use alcohol are 
more likely to abuse other substances one study showed a 57% 
prevalence of former alcohol use in young adults who report pre-
scription pain reliever abuse [26,27]. Given these correlations it is 
important to consider the sequence in which one can often begin 
with alcohol use and graduate on to non-medical use of prescription 
pain relievers as it may better develop and widen the understanding 
of this complex epidemic [28]. 
Alcohol use is a rather socially accepted and well integrated aspect 
of our society [29].  One may find a social drink to be quite a relief 
yet refrain from using the substance addictively due to its effects 
which are rather hard to conceal, i.e. smell, slurred speech, loss of 
balance and things of this nature. A prescription drug however, 
when introduced to this individual, can be quite appealing in that it 
is easier to conceal, at least initially, and provides the same relief. 
Recent studies have in fact shown a link between alcohol consump-
tion specifically and a propensity for non- medical use of prescrip-
tion drugs [30-34]. Therefore, I propose the following hypothesis: 
H4: As the frequency of daily alcohol consumption per week in-
creases, the likelihood of using non-medical prescription pain reliev-
ers increases. 
Research Design
Data & Ethics
The data for this study came from the National Survey on Drug Use 
and Health, conducted by the Substance Abuse and Mental Health 
Services Administration (SAMHSA), an agency within the U.S. 
Department of Health and Human Services which primarily meas-
ures the prevalence and correlates of drug use in the United States 
[35]. The study was conducted using the CAI method (computer 
assisted personal interviewing), and it covered individuals aged 12 
and older (N=67,838). However, for the purpose of this study, the 
sample was reduced to people who were at least 18 years old 
(N=54,959). 
 The researchers conducting the secondary data analysis main-
tained the highest ethical standards. The dataset analyzed is avail-
able to the general public and does not have present any identifying 
information about any participants. Moreover, the SAMHSA main-
tained the highest ethical standards in the initial collection of the 
data [35].  
Measures
The dependent variable used throughout this study was non-
medical prescription pain reliever use (See Table #1). The variable 
was based upon the following survey question: “Have you ever, 
even once, used any type of prescription pain reliever that was not 
prescribed to you or that you took for the experience or feeling it 
caused” (coded “Yes” = 1, “No”=0). 
The independent variables utilized fell under the categories of 
“Mental Health”, “Adult Depression”, and “Alcohol.” First, depres-
sion was measured using the survey question, “In the last thirty 
days have you experienced periods of depression lasting several 
days or longer” (0= “No” and 1=“Yes”). Second, mental distress 
was operationalized by the survey question, “In the last 30 days 
how frequently have you experienced thoughts of hopelessness.” 
The response options were; (1) “All of the time,” (2) “Most of the 
time,” (3) “Some of the time,” (4) “A little of the time,” and (5) 
“None of the time,” but it was recoded as (0) “Never” (“None of 
the Time”)  (1) =“Sometimes” (“Some of the time” and “A little of 
the time”), and (2) “Often” (“All of the time” and “Most of the 
time”). Third, social anxiety was operationalized by the survey ques-
tion, “In the last thirty days how much difficulty have you had talk-
ing to strangers?” The questions response options were (1) “No dif-
ficulty,” (2) “Mild difficulty,” (3) “Moderate difficulty,” (4) “Severe 
Difficulty,” and (5) “Did Not Participate,” but it was recoded as (0) 
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“No Difficulty”, (1) “Some Difficulty” (“Mild Difficulty” and “Moderate Difficulty”), (2) “Severe Difficulty,” and (3) “Did Not Participate.” 
Finally, alcohol consumption was measured using the survey question, “On average, how many days did you drink an alcoholic beverage each 
week during the past 12 months.” The response options ranged from 0 to 7.  Initially the survey question only dealt with individuals who re-
ported drinking, and essentially excluded those who did not drink assigning it a value (99). For the purpose of this study, however, the value of 
(99) was recoded to be (0), in order to account for individuals who reported not drinking at all. 
The control variables in this study were age, education, income, and gender. The variables age and income were initially scale variables that 
were recoded into categorical variables. Initially age included those aged 12-17 years old however for this study these values were excluded 
and only those aged 18 or older were considered. The final coding for age was as follows; (0) 18-25, (1) 26-34, (2) 35 and older. The finally 
coding for income was as follows; (0) less than 20,000, (1) 20,000-49,999, (2) 50,000-74,999, (3) 75,000 or more. The variable of education 
was a categorical variable initially containing 11 response options which were as follows; (1) “5th grade or less,” (2) “6th grade,” (3) “7th 
grade,” (4) “8th grade,” (5) “9th grade,” (6) “10th grade,” (7) “11th grade,” (8) “12th grade,” (9) “Freshman/13th year,” (10) “Sophomore/ 
14th year or Junior/ 15th year,”(11) “Senior /16th year or Grad/Prof School.” The response options 1-7 were recoded (0) “Less Than High 
school;” response option 8 was recoded as (1) “High School Graduate;” response options 9 and 10 were recoded as (2) “Some College;” and 
response option 11 was recoded as (3) “College Graduate.”. Gender was coded as (0) “Male” and (1) “Female.” 
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Findings
Out of 54,900 respondents about 85% (85.3%) stated they had never used prescription pain relievers non-medically while about 15% (14.7%) 
stated that they did use prescription pain relievers non-medically. According to the binary multivariate logistic regression analysis about 17% 
(Nagelkerke r²= 0.17) of the variance in non-medical prescription pain reliever use can be explained by periods of depression, mental distress, 
social anxiety, and alcohol consumption (Model x²= 1285.56; p<0.001). First, consistent with H1, those who are depressed are about 60% 
more likely to use prescription pain relievers for non- medical reasons than those who do not report frequent periods of depression (Exp[β]= 
1.61; p<0.001). Second, consistent with H2, those who experience mental distress often are about 58% more likely to report the use of prescrip-
tion pain relievers for non-medical reasons than those who do not (Exp[β]= 1.58; p<0.001). 
Consistent with H3 those who experience social anxiety are about 67% more likely to report non-medical prescription pain reliever misuse 
than those who do not experience social anxiety (Exp[β]= 1.67; p<0.001). Consistent with H4, as number of days per week that one reports 
consuming alcohol increases, the likelihood of reporting non-medical prescription pain reliever use increases by about 40% (Exp[β]= 1.40; 
p<0.001). 
Regarding the control variables, although the findings regarding gender was consistent with previous research, the findings related to age, edu-
cation, and income were surprising. Specifically, women were just over 27% less likely than men to use prescription pain relievers for non-
medical purposes (Exp[β]=0.73; p<0.001). People between the ages of 26 and 34 are just over 19% more likely to use prescription pain reliev-
ers for non-medical purposes than people between the ages of 18 and 25 (Exp[β]=1.19; p<0.05); however, people who are 35 years old or older 
were over 50% less likely to use prescription pain relievers for non-medical purposes than those between the ages of 18 and 25 (Exp[β]=0.49; 
p<0.001). Moreover, people with a college degree had the only statistically significant difference in the use of prescription pain relievers for 
non-medical purposes than those with less than a high school degree. Interestingly, people with a college degree were just over 17% less likely 
to use prescription pain relievers for non-medical purposes than people with less than a high school degree (Exp[β]=0.83; p<0.05). Income, 
however, was surprisingly statistically insignificant. 
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Discussion
This study sought to examine non-medical prescription pain re-
liever use, alcohol consumption, mental health, and the correlations 
that exist between these variables. The findings indicate that indeed 
certain risky behaviors and mental health conditions correlate di-
rectly with a propensity for non-medical prescription pain reliever 
use. The findings in this study can potentially assist healthcare pro-
viders in safer prescribing practices as well as other practical appli-
cations. With a broader knowledge of conditions that correlate with 
the use of prescription pain relievers for non-medical reasons the 
medical community can engage in safer prescribing of this excep-
tionally potent medication. 
The findings of the analysis relating to non- medical prescription 
pain reliever misuse, periods of depression (H1), mental distress 
(H2), and social anxiety (H3) support previous research which 
shows comorbidity between common mental health diagnosis and 
prescription pain reliever use [9,36]. The analysis shows a very sig-
nificant increase in propensity for non-medical prescription pain 
reliever misuse and periods of depression as well as frequency of 
mental distress and social anxiety. This increased propensity could 
be linked to a theory known as “chemical disassociation”, a chemi-
cally induced form of psychogenic disassociation [37]. The individ-
ual, as a result of his or her mental illness, finds realty impossible to 
endure and thus seeks relief via “chemical disassociation” or self- 
medication [38-40]. 
The relief this medication provides unfortunately becomes contrain-
dicative after a certain period of time, in that the initial mental pain 
in which it originally served to numb comes back in greater degree 
[41]. The mental pain that the medication was intended to reduce is 
only eased for a period of time, after the medication wears off the 
individual is met with the previous pain as well as the pain of his or 
her actions such as; guilt, remorse, and shame. The cycle of this 
pain can in turn foster dependence as the individual requires more 
medication each time to reduce the level of pain he or she feels. 
The significant correlation in these findings can be helpful to pro-
viders in the healthcare community (i.e. counselors, primary care 
physicians, specialists) as well as any party who has a potential in-
fluence on the individuals use of prescription pain relievers (friends 
and loved ones i.e. social circle). Particularly of interest to the indi-
viduals in one’s social circle are the findings related to H4 which 
found that as alcohol consumption increased individual’s propensity 
for the use of prescription pain-relievers for non-medical reasons 
increased significantly. Alcohol consumption being more widely 
accepted as a social adhesive in many situations can serve to demon-
strate the level of risk that one may have to abuse pain relievers 
which may have initially been prescribed for medical reasons.  
Rather serendipitous findings, however, were the insignificance of 
income and the particular significance of age and education. First, 
the findings demonstrate that the prescription drug epidemic has its 
impact on the individual regardless of socio-economic status, and 
that, contrary to commonsense notions, drug abuse is not exclusive 
to certain income brackets. Second, those who are between the ages 
of 26 and 34 were of a significantly higher risk to abuse prescrip-
tion pain relievers than those who were between the ages of 18 and 
25. These findings invoke deeper thought in that this age bracket 
would typically be considered to be in their “prime.” One’s body is 
generally considered to be in excellent shape at this time and often 
recovers quickly from any accrued injuries.  This claim is not sub-
stantiated however due to the findings that they seem to be suffer-
ing the most from a propensity to abuse prescription pain relievers. 
Finally, those who reported having a college degree did demon-
strate a less significant propensity for non-medical prescription pain 
reliever use than those who reported simply a high school educa-
tion. 
Limitations
The dataset used in this study is statistically representative of the 
U.S. adult population however it had a few substantive and opera-
tional limitations. The variable of depression in H1 was dichoto-
mous (1) “yes” (0) “no” which did not allow for a clear understand-
ing of the severity of depression one experienced. Though the vari-
ables for H2 and H3 are linked directly to the operationalized defini-
tions in the hypothesis they are not the sole characteristics of said 
conditions. This allows for some limitations on understanding the 
impact of independent variables in H2 and H3 on the dependent 
variable. In future research scholars, could potentially expand each 
hypothesis into more variables associated with each condition essen-
tially providing a single, more in-depth, study per hypothesis. The 
control variables also invoke the need for greater research on social 
factors that influence this epidemic, this study only briefly dis-
cusses these factors as they were not the primary focus of the re-
search. 
Conclusions
Prescription drug abuse has reached epidemic proportions nation-
wide. The findings of this study further reinforce the notion that 
substance abuse correlates directly with mental health as well as 
risky behaviors. The connection that this study makes between men-
tal health, risky behavior and propensity for non-medical prescrip-
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tion pain reliever use will hopefully inspire scholars to further exam-
ine this devastating social problem and its correlating conditions. 
The research in this study only addressed a small piece of the com-
plex issue of prescription pain reliever abuse in America. Given 
these findings however and the impact which this epidemic has al-
ready had on the American people it is my hope that this study will 
beckon scholars of the scientific community to expedite further re-
search on this issue.  
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